57 startups in Cambridge filed a Form D in the last 12 months. Together they reported $1.29B sold in 51 new rounds. The median round was $8.0M.
Startups
57
filed in 12 months
Reported new funding
$1.29B
51 rounds
Median round
$8.0M
new rounds
Largest rounds
Latest filings
| Company | Industry | Filed | Amount sold | Investors |
|---|---|---|---|---|
| Healthcare | Nov 13, 2026 | $29.8M ↗ | 21 | |
| Artificial Intelligence | Nov 12, 2026 | $540K ↗ | 11 | |
| Biotech & Pharma | Nov 10, 2026 | $474K ↗ | 7 | |
| Energy & Climate | Nov 4, 2026 | $200K ↗ | 4 | |
| Biotech & Pharma | Oct 30, 2026 | $500K ↗ | 1 | |
| Healthcare | Oct 23, 2026 | $1.0M ↗ | 25 | |
| Artificial Intelligence | Oct 22, 2026 | $75,240 ↗ | 2 | |
| Biotech & Pharma | Oct 21, 2026 | $3.0M ↗ | 4 | |
| Healthcare | Oct 20, 2026 | $1.8M ↗ | 9 | |
| Energy & Climate | Oct 7, 2026 | $7.1M ↗ | 11 | |
| Biotech & Pharma | Sep 25, 2026 | $2.0M ↗ | 2 | |
| Biotech & Pharma | Sep 21, 2026 | $56.2M ↗ | 6 | |
| Healthcare | Sep 17, 2026 | $486K ↗ | 9 | |
| Energy & Climate | Aug 24, 2026 | $18.3M ↗ | 7 | |
| Healthcare | Aug 4, 2026 | $505K ↗ | 7 |
Cambridge companies 176
| Company | Industry | City | Latest filing | Latest raise |
|---|---|---|---|---|
Nanopath IncRapid molecular tests for clinicians diagnosing women’s pelvic and gynecologic infections | Healthcare | Cambridge | Nov 13, 2026 | $29.8M |
CipherSonic Labs Inc.Encrypted AI infrastructure for enterprises handling sensitive data. | Artificial Intelligence | Cambridge | Nov 13, 2026 | $540K |
Sutol Bio, Inc.Monthly oral drug-delivery platform for people with chronic conditions. | Biotech & Pharma | Cambridge | Nov 10, 2026 | $474K |
Muon Vision Inc.Muon tomography technology for mining companies to monitor heap leaches, tailings dams, and undergrou… | Energy & Climate | Cambridge | Nov 4, 2026 | $200K |
| Biotech & Pharma | Cambridge | Oct 30, 2026 | $500K | |
OrthoIQ, Inc.Developing a smart impactor that tells hip replacement surgeons when an implant is fully seated. | Healthcare | Cambridge | Oct 23, 2026 | $1.0M |
Twintual Inc.AI assistant that drafts replies across email and chat apps for professionals and teams. | Artificial Intelligence | Cambridge | Oct 22, 2026 | $75K |
Quiver Holdings Inc.Drug discovery platform and antisense medicines for brain disorders and chronic pain. | Biotech & Pharma | Cambridge | Oct 21, 2026 | $3.0M |
Nocturnal Inc.Sleep technology using data and insights to improve people's lives. | Healthcare | Cambridge | Oct 20, 2026 | $1.8M |
Cambridge Heavy Industries Inc.Develops compact fusion machines to produce fuel for fusion reactors. | Energy & Climate | Cambridge | Oct 7, 2026 | $7.1M |
Way Biosolutions, Inc.WayBio builds and modifies DNA plasmids for research and biotechnology teams. | Biotech & Pharma | Cambridge | Sep 25, 2026 | $2.0M |
Typewriter Therapeutics, Inc.All-RNA medicines that insert whole genes, for cancer, autoimmune and rare genetic diseases. | Biotech & Pharma | Cambridge | Sep 21, 2026 | $56.2M |
SurgiBox Inc.Makes portable surgical environments for surgeons working in hospitals and field settings. | Healthcare | Cambridge | Sep 17, 2026 | $486K |
Mantel Capture, Inc.Develops carbon capture systems for industrial facilities and power plants. | Energy & Climate | Cambridge | Aug 24, 2026 | $18.3M |
Aperon, Inc.Aperon builds documentation software for clinical trial sponsors. | Healthcare | Cambridge | Aug 4, 2026 | $505K |
NextPoint Therapeutics, Inc.Develops targeted cancer treatments for patients with solid tumors. | Biotech & Pharma | Cambridge | Jul 30, 2026 | $33.7M |
Tristar AI Inc.AI inspection systems help manufacturers detect defects on production lines. | Artificial Intelligence | Cambridge | Jul 21, 2026 | $13.0M |
Farsight AI, Inc.AI software helps financial firms prepare pitch decks, financial models and investment memos. | Artificial Intelligence | Cambridge | Jul 16, 2026 | $10.0M |
AdvanCell, Inc.Develops targeted radiation treatments for people with cancer. | Biotech & Pharma | Cambridge | Jul 16, 2026 | $218.3M |
Walden Robotics, Inc.General-purpose robots for manufacturing and logistics companies. | Industrial & Robotics | Cambridge | Jul 15, 2026 | $302.0M |
Clover Fast Food, Inc.Serves restaurant meals to diners. | Consumer & Retail | Cambridge | Jul 9, 2026 | $2.5M |
LinqAlpha, Inc.AI investment research software for hedge funds, asset managers and investment banks. | Artificial Intelligence | Cambridge | Jul 9, 2026 | $21.9M |
Datalign Advisory, Inc.Matches people seeking financial advice with advisory firms. | FinTech & Financial Services | Cambridge | Jun 16, 2026 | $800K |
| Not classified yet | Cambridge | Jun 11, 2026 | $65K | |
| Biotech & Pharma | Cambridge | Jun 3, 2026 | $9.9M | |
Elemental Machines, Inc.Monitoring hardware and software for laboratories and manufacturing facilities. | Biotech & Pharma | Cambridge | May 29, 2026 | $5.7M |
Verve, Inc.Makes wearable lifting assistance devices for workers who repeatedly lift objects. | Industrial & Robotics | Cambridge | May 29, 2026 | $12.7M |
Sea Pharmaceuticals, LLCDevelops potential oral medicines for people with tinnitus, epilepsy and sporadic ALS. | Biotech & Pharma | Cambridge | May 20, 2026 | $71K |
Blitzy, Inc.AI software that helps enterprise development teams build and modernize applications. | Artificial Intelligence | Cambridge | May 15, 2026 | $188.7M |
Tycho AI Inc.Tycho.AI makes autonomous drones and navigation systems for military users. | Aerospace & Defense | Cambridge | May 13, 2026 | $8.0M |
Thinkstruct, Inc.AI patent research and analysis software for legal teams. | Enterprise Software | Cambridge | May 12, 2026 | $1.0M |
Axoft, Inc.Develops brain implants intended to help people with neurological disorders. | Healthcare | Cambridge | May 7, 2026 | $34.2M |
Artax Biopharma, Inc.Develops oral drug candidates for people with autoimmune diseases. | Biotech & Pharma | Cambridge | May 5, 2026 | $19.0M |
GelMEDIX, Inc.Develops regenerative therapies for people with vision loss. | Biotech & Pharma | Cambridge | Apr 30, 2026 | $747K |
Marble, Inc.Marble sells AI-powered automation equipment to meat processors. | Industrial & Robotics | Cambridge | Apr 28, 2026 | $14.4M |
Foundation Alloy Technology Explorations, Inc.Develops metal alloys and manufacturing processes for engineers making industrial parts. | Industrial & Robotics | Cambridge | Apr 22, 2026 | $19.9M |
| Biotech & Pharma | Cambridge | Apr 17, 2026 | $2.2M | |
HyperLight CorpMakes optical chips and modulators for data centers and telecommunications networks. | Industrial & Robotics | Cambridge | Apr 17, 2026 | $52.9M |
| Not classified yet | Cambridge | Apr 16, 2026 | $500K | |
Pi Health Inc.Clinical trial software and research services for pharmaceutical and biotechnology teams. | Healthcare | Cambridge | Apr 7, 2026 | $8.6M |
Stipple Bio, Inc.Develops targeted cancer medicines for people with cancer. | Biotech & Pharma | Cambridge | Apr 6, 2026 | $65.1M |
Aptamino, Inc.Develops antibody drugs designed to be taken as pills by patients. | Biotech & Pharma | Cambridge | Apr 6, 2026 | $8.0M |
Sora Fuel CorpMakes jet and diesel fuel from air, water and renewable energy for transportation. | Energy & Climate | Cambridge | Mar 31, 2026 | $14.6M |
Novolyze, Inc.Software for food and beverage companies to manage food safety and quality processes. | Enterprise Software | Cambridge | Mar 31, 2026 | $677K |
Apnimed, Inc.Develops oral medicines for people with sleep apnea and other sleep-related breathing diseases. | Biotech & Pharma | Cambridge | Mar 27, 2026 | $24.9M |
Pacegenix, Inc.Develops treatments for people with heart rhythm disorders. | Biotech & Pharma | Cambridge | Mar 26, 2026 | $22.5M |
DNP Therapeutics Inc.Develops potential treatments for viral infections and neurodegenerative disorders. | Biotech & Pharma | Cambridge | Mar 23, 2026 | $470K |
CavilinQ, Inc.Develops hardware to connect quantum processors for quantum computing. | Industrial & Robotics | Cambridge | Mar 19, 2026 | $8.7M |
MacroCycle Technologies Inc.Produces recycled polyester resin for textile and packaging manufacturers. | Industrial & Robotics | Cambridge | Mar 3, 2026 | $2.9M |
| Biotech & Pharma | Cambridge | Jan 21, 2026 | $37.5M |
How this page is built
Startups are the private companies counted as startups (see our startup funding data), placed by the address on their latest Form D. Registered-agent and virtual-office addresses are not counted as a location. Public companies, foreign issuers and business-combination filings are excluded.